Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02401802
Other study ID # DIETCOL
Secondary ID
Status Completed
Phase N/A
First received March 17, 2015
Last updated February 14, 2017
Start date January 2015
Est. completion date December 2015

Study information

Verified date February 2017
Source Parc de Salut Mar
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This trial will compare the efficacy of 2 different sets of dietary recommendations to be followed before colon cleansing for colorectal cancer screening colonoscopy.


Description:

There is no enough evidence in the literature to recommend a low-fiber diet for screening colonoscopy. Although evidence of benefit of a liquid diet is minimal and there is a growing body of evidence about the benefits of a liberalized diet, a high degree of heterogeneity in the clinical trials comparing the diet modifications before colonoscopy prevents a formal recommendation in current guidelines. A low-fiber diet the day before colonoscopy may result in same efficacy of bowel cleanliness, with an improved tolerability and acceptability.

All consecutive patients of a population-based colorectal screening cancer program referred for a colonoscopy will be invited to participate in the study. After obtaining informed consent, they will be randomized to one of the groups: liquid diet or low-fiber diet. The will be interviewed by a registered research nurse, and they will be provided with written instructions for bowel preparation and questionnaires for registering the data of the study. The day of the colonoscopy, questionnaires will be collected and endoscopists blinded for the study bowel preparation will perform the colonoscopy. Patients will be contacted for adverse events and a general satisfaction questionnaire, 3 days after colonoscopy.


Recruitment information / eligibility

Status Completed
Enrollment 276
Est. completion date December 2015
Est. primary completion date June 2015
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion criteria:

- Consecutive patients referred for a colonoscopy in a population-based colorectal screening program.

Exclusion criteria:

- Unwillingness to participate.

- Inability to follow instructions

- Active inflammatory bowel disease

- Incomplete colonoscopies for technical reasons or contraindication as evaluated by the endoscopist

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Low-residue diet
Subjects will be instructed by members of the research team to follow a standardized low residue diet for 4 days
Usual care
Subjects will be instructed by members of the research team to follow a low-residue diet for 3 days followed by 24 hours of liquid diet

Locations

Country Name City State
Spain Hospital del Mar Barcelona

Sponsors (1)

Lead Sponsor Collaborator
Parc de Salut Mar

Country where clinical trial is conducted

Spain, 

References & Publications (1)

Soweid AM, Kobeissy AA, Jamali FR, El-Tarchichi M, Skoury A, Abdul-Baki H, El-Zahabi L, El-Sayyed A, Barada KA, Sharara AI, Mourad F, Arabi A. A randomized single-blind trial of standard diet versus fiber-free diet with polyethylene glycol electrolyte solution for colonoscopy preparation. Endoscopy. 2010 Aug;42(8):633-8. doi: 10.1055/s-0029-1244236. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Inadequate bowel preparation. The efficacy of bowel preparation will be rated by blinded endoscopists using the Boston Bowel Preparation Scale (BBPS). Colonoscopies with a BBPS score of less than 5 points, or any segment rated less than 2 points will be considered with an inadequate bowel preparation 1 hour after the colonoscopy
Secondary Cecal intubation rate Ratio of successful cecal intubations in each study arm 1 hour after the colonoscopy
Secondary Adenoma detection rate Ratio of polyps and adenomas detected in each study arm 1 hour after the colonoscopy
Secondary Polyp detection rate Ratio of polyps and adenomas detected in each study arm 1 hour after the colonoscopy
Secondary Abdominal pain Each participant will rate his/her experience in an analogue visual scale 6 hours after finishing bowel preparation
Secondary Nausea Each participant will rate his/her experience in an analogue visual scale 6 hours after finishing bowel preparation
Secondary Hunger Each participant will rate his/her experience in an analogue visual scale 6 hours after finishing bowel preparation
Secondary Bloating Each participant will rate his/her experience in an analogue visual scale 6 hours after finishing bowel preparation
Secondary Adverse events Description of all spontaneously reported adverse events. 30 days after the colonoscopy
Secondary Adherence to the planned bowel cleansing method (questionnaire) Each participant will rate his/her experience in a questionnaire. 6 hours after finishing bowel preparation
Secondary Acceptability of the preparation (interference with work, leisure activities or sleep Each participant will rate his/her experience in a questionnaire. 6 hours after finishing bowel preparation
See also
  Status Clinical Trial Phase
Completed NCT02503696 - Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD) N/A
Terminated NCT01119027 - Assessing Effectiveness of Laparoscopic Colorectal Surgical Skills N/A
Completed NCT01063231 - Evaluation of PillCamâ„¢ Colon 2 in Visualization of the Colon Phase 3
Completed NCT04074577 - Computer Aided Detection, Tandem Colonoscopy Study N/A
Not yet recruiting NCT04087824 - Deep Learning Algorithm for Recognition of Colonic Segments. N/A
Completed NCT03559543 - Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma Phase 2
Terminated NCT02503631 - Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Completed NCT01600209 - Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing N/A
Completed NCT01260168 - Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies N/A
Completed NCT00604162 - PillCamâ„¢ Colon Capsule Endoscopy (PCCE) in the Visualization of the Colon Phase 3
Recruiting NCT04598880 - Comparison of 1 Liter PEG With Ascorbate and Sodium Picosulfate / Magnesium Citrate for High Quality Colon Cleansing Phase 4
Completed NCT01738425 - A Clinical Phase I Study on GIC-1001 in Healthy Volunteers Phase 1
Completed NCT04080843 - Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients Phase 2
Terminated NCT04644315 - A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors Phase 2
Completed NCT02291445 - Comparing a 182mg Colon-targeted-delivery Peppermint Oil Capsule (Tempocol-ColoPulse®) and a 182mg Enteric-coated Peppermint Oil Capsule (Tempocol®), a Pharmacokinetic Study Phase 2
Completed NCT03037385 - Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors Phase 1/Phase 2
Completed NCT03139942 - Optical Polyp Testing for In Vivo Classification N/A
Completed NCT04263818 - Endoscopist and Endoscope Motions During Colonoscopy N/A
Recruiting NCT05923918 - A Study to Evaluate Safety and Efficacy of PBK_M2101 Phase 3
Completed NCT02647866 - Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis Phase 2